Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Methotrexate | 0.31623 | uM | 3 | 5000.00 | 4101.40 | 3050.00 | 5695.67 | 0.5348 | -0.4724 |
| SK-BR-3 | Taxol | 0.01 | uM | 3 | 5000.00 | 4101.40 | 2533.33 | 5695.67 | 0.4465 | -0.6416 |
| SK-BR-3 | Omipalisib | 1 | uM | 3 | 5000.00 | 4101.40 | 2265.67 | 5695.67 | 0.3965 | -0.7103 |
| SK-BR-3 | Methotrexate | 0.1 | uM | 3 | 5000.00 | 4101.40 | 4406.00 | 5695.67 | 0.7737 | 0.1487 |
| SK-BR-3 | Taxol | 0.00016596 | uM | 3 | 5000.00 | 4101.40 | 5757.00 | 5695.67 | 1.0127 | 1.0930 |
| SK-BR-3 | Taxol | 0.0031623 | uM | 3 | 5000.00 | 4101.40 | 5163.00 | 5695.67 | 0.9041 | 0.5889 |
| SK-BR-3 | Omipalisib | 0.01 | uM | 3 | 5000.00 | 4101.40 | 3864.33 | 5695.67 | 0.6761 | -0.1353 |
| SK-BR-3 | Omipalisib | 0.31623 | uM | 3 | 5000.00 | 4101.40 | 2604.67 | 5695.67 | 0.4571 | -0.6205 |
| SK-BR-3 | Methotrexate | 0.0016596 | uM | 3 | 5000.00 | 4101.40 | 5716.00 | 5695.67 | 1.0038 | 1.0208 |
| SK-BR-3 | Methotrexate | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 5564.67 | 5695.67 | 0.9768 | 0.8973 |
| SK-BR-3 | Methotrexate | 3.1623 | uM | 3 | 5000.00 | 4101.40 | 3031.33 | 5695.67 | 0.5346 | -0.4773 |
| SK-BR-3 | Methotrexate | 10 | uM | 3 | 5000.00 | 4101.40 | 2985.67 | 5695.67 | 0.5253 | -0.4954 |
| SK-BR-3 | Taxol | 0.00033113 | uM | 3 | 5000.00 | 4101.40 | 5715.00 | 5695.67 | 1.0053 | 1.0601 |
| SK-BR-3 | Taxol | 0.001 | uM | 3 | 5000.00 | 4101.40 | 5704.00 | 5695.67 | 1.0022 | 1.0225 |
| SK-BR-3 | Omipalisib | 0.0016596 | uM | 3 | 5000.00 | 4101.40 | 5057.00 | 5695.67 | 0.8872 | 0.5355 |
| SK-BR-3 | Omipalisib | 0.0033113 | uM | 3 | 5000.00 | 4101.40 | 4599.33 | 5695.67 | 0.8072 | 0.2553 |
| SK-BR-3 | Omipalisib | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 3243.67 | 5695.67 | 0.5687 | -0.4007 |
| SK-BR-3 | Omipalisib | 0.1 | uM | 3 | 5000.00 | 4101.40 | 2700.33 | 5695.67 | 0.4732 | -0.5889 |
| SK-BR-3 | Omipalisib | 3.1623 | uM | 3 | 5000.00 | 4101.40 | 1894.67 | 5695.67 | 0.3330 | -0.8015 |
| SK-BR-3 | Omipalisib | 10 | uM | 3 | 5000.00 | 4101.40 | 2063.67 | 5695.67 | 0.3625 | -0.7660 |
| SK-BR-3 | Methotrexate | 0.0033113 | uM | 3 | 5000.00 | 4101.40 | 5810.67 | 5695.67 | 1.0210 | 1.1071 |
| SK-BR-3 | Methotrexate | 0.01 | uM | 3 | 5000.00 | 4101.40 | 5830.67 | 5695.67 | 1.0259 | 1.1591 |
| SK-BR-3 | Methotrexate | 1 | uM | 3 | 5000.00 | 4101.40 | 3030.33 | 5695.67 | 0.5333 | -0.4805 |
| SK-BR-3 | Taxol | 0.1 | uM | 3 | 5000.00 | 4101.40 | 2222.00 | 5695.67 | 0.3939 | -0.7290 |
| SK-BR-3 | Taxol | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 2315.67 | 5695.67 | 0.4096 | -0.7057 |